UPDATED Apr 25, 2024
Strong Balance Sheet Stocks: companies with a Health score of at least 4, ordered by Health score.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
IQST | US$0.34 | 21.7% | 230.1% | US$60.1m | n/a | PB7.2x | n/a | n/a | ||
SPOK | US$15.44 | 3.7% | 30.2% | US$310.9m | US$18.00 | PE19.8x | E10.3% | 8.1% | ||
IDT | US$36.31 | 1.1% | 8.4% | US$921.8m | n/a | PE24.9x | n/a | 0.6% | ||
IGLD.F | US$1.97 | 0% | n/a | US$4.4m | n/a | PB2.7x | n/a | n/a | ||
CIBY | US$1,820.00 | 0% | 2.2% | US$23.1m | n/a | PE80.3x | n/a | n/a | ||
SURG | US$3.36 | -9.9% | -23.3% | US$64.8m | US$7.00 | PE3.1x | E-26.5% | n/a | ||
FULO | US$0.26 | -0.04% | 3.8% | US$5.1m | n/a | PE11x | n/a | 5.1% | ||
MACT | US$7.00 | 0.04% | n/a | US$18.0m | n/a | PE4.6x | n/a | n/a | ||
NXPL | US$1.21 | -8.0% | -50.4% | US$22.7m | n/a | PB0.7x | n/a | n/a | ||
UCL | US$1.41 | 2.5% | -64.8% | US$52.9m | US$9.50 | PE18.8x | S16.4% | n/a | ||
OOMA | US$6.80 | -3.1% | -45.7% | US$179.7m | US$15.60 | PB2.3x | E45.5% | n/a | ||
ATEX | US$31.89 | 1.9% | -0.6% | US$590.6m | US$70.25 | PE37.3x | E-87.7% | n/a | ||
SHEN | US$13.95 | -3.5% | -26.6% | US$760.9m | US$26.00 | PE94.7x | E-132.7% | 0.6% | ||
ASTS | US$2.19 | 2.3% | -57.6% | US$554.8m | US$12.68 | PB3.1x | E55.3% | n/a | ||
CRGE.Q | US$0.0075 | -36.4% | -99.4% | US$1.6m | n/a | PB0.07x | n/a | n/a | ||
VPLM | US$0.013 | -3.7% | -67.1% | US$41.6m | n/a | PB20x | n/a | n/a | ||
LICT | US$16,000.00 | 0% | -14.4% | US$271.5m | n/a | PE26.8x | n/a | n/a | ||
FNGR | US$3.15 | -1.9% | 87.5% | US$166.0m | n/a | PS4.1x | n/a | n/a |